Cidara Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Cidara Therapeutics using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-07 | $-2.38 | $-4.25 | 44.0 % |
Q2 | 2024-08-13 | $-2.05 | $-4.10 | 50.0 % |
Q1 | 2024-05-15 | $-2.28 | $-0.80 | -185.0 % |
Q4 | 2024-04-22 | $-0.80 | $-2.00 | 60.0 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-07 | $0 | $430.00K | -100.0 % |
Q2 | 2024-08-13 | $302.00K | $4.70M | -93.6 % |
Q1 | 2024-05-15 | $8.46M | $9.03M | -6.28 % |
Q4 | 2024-04-22 | $17.58M | $11.54M | 52.4 % |
Cidara Therapeutics (CDTX) is scheduled to report earnings on April 21, 2025. The last reported earnings were for reported on November 7, 2024 for Q3.
The Actual EPS was $-2.38, which beat the estimate of $-4.25.
The Actual Revenue was $0K, which missed the estimate of $430K.
Browse earnings estimates, EPS, and revenue on all stocks.